These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 23789792)
1. Mechanism of platelet activation induced by endocannabinoids in blood and plasma. Brantl SA; Khandoga AL; Siess W Platelets; 2014; 25(3):151-61. PubMed ID: 23789792 [TBL] [Abstract][Full Text] [Related]
2. Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors. Brantl SA; Khandoga AL; Siess W Platelets; 2014; 25(6):465-6. PubMed ID: 24102401 [No Abstract] [Full Text] [Related]
3. The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors. Baldassarri S; Bertoni A; Bagarotti A; Sarasso C; Zanfa M; Catani MV; Avigliano L; Maccarrone M; Torti M; Sinigaglia F J Thromb Haemost; 2008 Oct; 6(10):1772-9. PubMed ID: 18647220 [TBL] [Abstract][Full Text] [Related]
4. 2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors. Keown OP; Winterburn TJ; Wainwright CL; Macrury SM; Neilson I; Barrett F; Leslie SJ; Megson IL Br J Clin Pharmacol; 2010 Aug; 70(2):180-8. PubMed ID: 20653671 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533 [TBL] [Abstract][Full Text] [Related]
6. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55. Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039 [TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids control platelet activation and limit aggregate formation under flow. De Angelis V; Koekman AC; Weeterings C; Roest M; de Groot PG; Herczenik E; Maas C PLoS One; 2014; 9(9):e108282. PubMed ID: 25264625 [TBL] [Abstract][Full Text] [Related]
8. Activation of human platelets by 2-arachidonoylglycerol is enhanced by serotonin. Maccarrone M; Bari M; Del Principe D; Finazzi-Agrò A Thromb Haemost; 2003 Feb; 89(2):340-7. PubMed ID: 12574815 [TBL] [Abstract][Full Text] [Related]
9. [The endocannabinoid system and interference with thrombogenesis]. Kvasnicka T Vnitr Lek; 2010 Feb; 56(2):127-9. PubMed ID: 20329583 [TBL] [Abstract][Full Text] [Related]
10. 2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts. Gasperi V; Avigliano L; Evangelista D; Oddi S; Chiurchiù V; Lanuti M; Maccarrone M; Valeria Catani M Cell Cycle; 2014; 13(24):3938-47. PubMed ID: 25427281 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase. Gkini E; Anagnostopoulos D; Mavri-Vavayianni M; Siafaka-Kapadai A Platelets; 2009 Sep; 20(6):376-85. PubMed ID: 19811221 [TBL] [Abstract][Full Text] [Related]
12. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630 [TBL] [Abstract][Full Text] [Related]
13. Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2-Arachidonoylglycerol. Signorello MG; Leoncini G J Cell Biochem; 2016 May; 117(5):1240-9. PubMed ID: 26460717 [TBL] [Abstract][Full Text] [Related]
14. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856 [TBL] [Abstract][Full Text] [Related]
15. Targeting the cannabinoid system for pain relief? Chiou LC; Hu SS; Ho YC Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity. Grambow E; Strüder D; Klar E; Hinz B; Vollmar B Biofactors; 2016 Nov; 42(6):581-590. PubMed ID: 27151562 [TBL] [Abstract][Full Text] [Related]
17. Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures. Zareie P; Sadegh M; Palizvan MR; Moradi-Chameh H Metab Brain Dis; 2018 Jun; 33(3):939-948. PubMed ID: 29504066 [TBL] [Abstract][Full Text] [Related]
18. Anandamide activates human platelets through a pathway independent of the arachidonate cascade. Maccarrone M; Bari M; Menichelli A; Del Principe D; Agrò AF FEBS Lett; 1999 Mar; 447(2-3):277-82. PubMed ID: 10214961 [TBL] [Abstract][Full Text] [Related]
19. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. Berdyshev EV; Schmid PC; Krebsbach RJ; Schmid HH FASEB J; 2001 Oct; 15(12):2171-8. PubMed ID: 11641243 [TBL] [Abstract][Full Text] [Related]
20. Activation by 2-arachidonoylglycerol of platelet p38MAPK/cPLA2 pathway. Signorello MG; Giacobbe E; Leoncini G J Cell Biochem; 2011 Oct; 112(10):2794-802. PubMed ID: 21608016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]